All News Getein Biotech, Inc

Equities

603387

CNE100002RR9

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 17/05/2024 am IST			5-day change	1st Jan Change
9.44 ^CNY	-0.42%		-4.93%	-14.18%

29/04	Getein Biotech, Inc Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
29/04	Getein Biotech, Inc Reports Earnings Results for the Full Year Ended December 31, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Getein Biotech, Inc Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04	CI
Getein Biotech, Inc Reports Earnings Results for the Full Year Ended December 31, 2023	29/04	CI
Getein Biotech, Inc Reports Earnings Results for the Nine Months Ended September 30, 2023	27/23/27	CI
Getein Biotech, Inc Reports Earnings Results for the Half Year Ended June 30, 2023	28/23/28	CI
Getein Biotech, Inc Reports Earnings Results for the First Quarter Ended March 31, 2023	26/23/26	CI
Getein Biotech, Inc Reports Earnings Results for the Full Year Ended December 31, 2022	30/23/30	CI
Meihua International Unit, Getein Biotech to Develop COVID-19 Antigen Test Kits, Other In Vitro Diagnostic Products	11/23/11	MT
Meihua International Medical Technologies Co., Ltd. Enters into Strategic Partnership with Getein Biotech Inc. to Jointly Produce and Sell Covid-19 Antigen Test Kits and IVDs	11/23/11	CI
Getein Biotech Gets Regulatory Approval for COVID-19 Kit; Shares Up 9%	12/22/12	MT
Getein Biotech, Inc Reports Earnings Results for the Nine Months Ended September 30, 2022	26/22/26	CI
Yestar Healthcare, Getein Biotech End Investment Talks	24/22/24	MT
Getein Biotech, Inc Reports Earnings Results for the Half Year Ended June 30, 2022	23/22/23	CI
Yestar Healthcare Holdings Company Limited cancelled the transaction announced on April 8, 2022	23/22/23	CI
Getein Biotech, Inc Reports Earnings Results for the First Quarter Ended March 31, 2022	27/22/27	CI
Yestar Healthcare Holdings Company Limited announced that it expects to receive funding from Getein Biotech, Inc	08/22/08	CI
Getein Biotech, Inc Reports Earnings Results for the Full Year Ended December 31, 2021	11/22/11	CI
Sichuan Getein Biotechnology Co., Ltd. announced that it expects to receive CNY 30 million in funding from Getein Biotech, Inc	24/22/24	CI
Getein Biotech, Inc Reports Earnings Results for the Nine Months Ended September 30, 2021	27/21/27	CI
Getein Biotech, Inc Reports Earnings Results for the Half Year Ended June 30, 2021	17/21/17	CI
Tranche Update on Getein Biotech, Inc's Equity Buyback Plan announced on December 31, 2020.	30/21/30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Getein Biotech, Inc

Equities

603387

CNE100002RR9

All News

Filters